A diabetes drug called liraglutide might help calm down inflammation in joint cells and immune cells in mice, especially at certain doses.

12

Pro

0

Against

Evidence from Studies

Supporting (1)

12

Community contributions welcome

12

Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis

Cross-Sectional Study

Animal

2022 Jan 28

The study shows that liraglutide reduces key inflammation markers in joint cells, which supports the idea that it has strong anti-inflammatory effects in the lab.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis

Score: 12

DOI: 10.1038/s41598-022-05323-7

Similar Assertions

A diabetes drug called liraglutide might help protect cartilage by slowing down the breakdown of joint tissue in lab-grown mouse cells.

12

0

83%

When rat cartilage cells are stressed by sugar-related toxins, the diabetes drug liraglutide seems to calm down inflammation — suggesting it might help protect joints in conditions like diabetes.

8

0

77%

Liraglutide might help calm down harmful inflammation in joints by changing the behavior of immune cells in a lab dish.

12

0

74%

Liraglutide might help protect cartilage cells from dying when they're under stress, at least in lab studies with rat cells.

8

0

72%